DCF — SOUTH TEXAS SURGICAL HOSPITAL
Enterprise Value: $-119.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-119.0M
Enterprise Value
$-37.1M
PV of Cash Flows
$-81.9M
PV of Terminal Value
$-132.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $57.4M | $-7.7M | -13.0% | $-10.2M | $-9.2M |
| Year 2 | $59.1M | $-7.4M | -12.0% | $-9.9M | $-8.2M |
| Year 3 | $60.9M | $-7.0M | -11.0% | $-9.6M | $-7.2M |
| Year 4 | $62.7M | $-6.9M | -11.0% | $-9.5M | $-6.5M |
| Year 5 | $64.6M | $-6.9M | -11.0% | $-9.7M | $-6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-119.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$55.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13961099232405086
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5